CW: IBD / medical
Most IBD cooking advice is about what not to eat. This is something different — a first-person list of resources, tools, and recipes that have actually made cooking manageable with Crohn's or colitis.
Worth bookmarking if you're still figuring out your kitchen routine.
CW: IBD / medical
A systematic review of 7 studies — 5,721 adults switching from reference adalimumab to a biosimilar. Remission rates held at 74–90%. Biomarkers stable. This week also: overheated "IBD cause solved" headlines, stem cell therapy for fistulas, molecular scarring in healed Crohn's tissue, and a $180M biotech launch.
https://ibdmovement.com/week-of-june-15-21-2026-eight-ibd-research-stories-worth-reading/?utm_source=mastodon #IBD #CrohnsDisease #ChronicIllness
CW: IBD / medical
20+ years with Crohn's and I've tracked which sweeteners my gut actually tolerates. Monk fruit and stevia aren't the same answer — the difference surprised me and changed what I keep in the kitchen.
This week in IBD research: NIH identifies protective immune cells, FDA accepts vedolizumab for kids with IBD, and risankizumab long-term data. 6 studies, translated for real life.
Back pain with Crohn's disease? I'm navigating a possible ankylosing spondylitis diagnosis. Read my story on IBD Movement.
Intermittent fasting and Crohn's: after 20+ years with this disease, I've learned to approach any dietary change with measured skepticism. 16:8 sometimes reduces bloating and stabilizes energy — but it doesn't prevent flares or replace medication. Here's my honest take.
https://ibdmovement.com/how-intermittent-fasting-affects-my-crohns-disease/?utm_source=mastodon #CrohnsDisease #IBD
In IBD research this week: market projections through 2034, pediatric growth guidance, and one study explaining the IBD-to-colon-cancer mechanism. The last one is worth your time.
Biologics suppress your immune system — which changes everything about vaccination. Some vaccines are contraindicated. Some are required before starting. And timing around infusions actually matters.
After 20+ years with Crohn's, here's what I coordinate with my doctors.
IBD research has never felt more promising — or more overwhelming. Dual-pathway biologics, spatial transcriptomics, gut-brain connections. When the field advances faster than patients can process, what's the right way to engage?
Seven IBD research updates from May 25-31: iron deficiency markers, the gut-brain connection, Mayo Clinic on treatment resistance, and early GLP-1 data. Covers a lot — none of it changes treatment tomorrow.
